Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01694875 · ClinicalTrials.gov registry record
Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System
A clinical trial, sponsored by Gen-Probe, Incorporated.
- Completed
- Registry status
- 2,200
- Enrollment target
NCT01694875 is a clinical trial that has completed, run by Gen-Probe, Incorporated. The registered enrollment target is 2,200 participants.
The verdict
NCT01694875 has completed, sponsored by Gen-Probe, Incorporated.
- COMPLETED
- Registry status
- 2,200 participants
- Enrollment target
Study Summary
The objective of the clinical study is to evaluate the AHPV-GT Assay using the PANTHER System in cervical cancer screening. This objective will be accomplished in the ASC-US Study by evaluating the performance characteristics of the AHPV-GT Assay using the PANTHER System in a sample population of women with ASC-US Pap test results who were 21 years of age or older ("≥21 years of age") at the time of their Pap visit. For the Adjunct Study, this objective will be accomplished by evaluating the ability of the AHPV-GT Assay using the PANTHER System to identify women at increased risk of cervical disease in a sample population of women with negative (NILM)cytology results who were ≥30 years of age at the time of their Pap visit.
Interventions
- DEVICE APTIMA HPV Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2012-10 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01694875
The ClinicalTrials.gov registry entry for NCT01694875 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gen-Probe, Incorporated, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which APTIMA HPV Assay is the first listed.
NCT01694875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01694875 about?
NCT01694875 is a clinical study titled "Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System". The objective of the clinical study is to evaluate the AHPV-GT Assay using the PANTHER System in cervical cancer screening. This objective will be accomplished in the ASC-US Study by evaluating the performance characteristics of the AHPV-GT Assay using the PANTHER System in a sample population of w...
What is the current status of trial NCT01694875?
This trial is currently completed. The enrollment target is 2,200 participants. The study started on 2012-10. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01694875?
The interventions under investigation include: APTIMA HPV Assay (DEVICE).
Who is sponsoring clinical trial NCT01694875?
This trial is sponsored by Gen-Probe, Incorporated, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.